ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,903Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 487

$1.27M Total Retail Price of All Prescriptions

Rank: 1 out of 487

879 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 879 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 879 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 23,353 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
HYDROCODONE-ACETAMINOPHEN 1,348 1,198 S3 1 3
WARFARIN SODIUM 1,081 928 2 11
LEVOTHYROXINE SODIUM 1,045 953 3 1
FUROSEMIDE 1,002 896 4 7
OMEPRAZOLE 872 733 5 2
LISINOPRIL 821 693 6 5
SIMVASTATIN 773 614 7 4
POTASSIUM CHLORIDE 743 648 8 10
CITALOPRAM HBR 648 566 9 12
AMLODIPINE BESYLATE 639 579 10 6
METOPROLOL SUCCINATE 489 414 11 15
ESCITALOPRAM OXALATE 466 417 12 75
GABAPENTIN 452 350 13 13
FENTANYL 380 337 S2 14 36
TRAZODONE HCL 349 294 15 22
HYDROCHLOROTHIAZIDE 348 313 16 9
BACLOFEN 340 176 17 71
POLYETHYLENE GLYCOL 3350 334 298 18 56
DONEPEZIL HCL 320 284 19 38
METOPROLOL TARTRATE 305 297 20 17
SERTRALINE HCL 282 205 21 21
QUETIAPINE FUMARATE 278 229 22 69
ATORVASTATIN CALCIUM 277 250 23 18
ALENDRONATE SODIUM 276 229 24 27
ATENOLOL 275 221 25 23
LANTUS 262 196 26 44
TRAMADOL HCL 249 240 27 19
KLOR-CON M20 237 213 28 83
TAMSULOSIN HCL 234 213 29 25
LOSARTAN POTASSIUM 234 234 29 16
METFORMIN HCL ER 216 173 31 31
ALLOPURINOL 209 209 32 29
MIRTAZAPINE 204 179 33 59
PREDNISONE 203 172 34 37
SPIRONOLACTONE 200 177 35 43
NAMENDA 193 193 36 53
LEVETIRACETAM 190 137 37 130
VENLAFAXINE HCL ER 175 138 38 55
OXYBUTYNIN CHLORIDE ER 174 109 39 101
ROPINIROLE HCL 173 138 40 60
CYMBALTA 167 106 41 34
NOVOLOG 163 107 42 113
LOVASTATIN 148 131 43 30
CARBIDOPA-LEVODOPA 145 140 44 85
TRIAMCINOLONE ACETONIDE 141 106 45 81
MORPHINE SULFATE ER 138 111 S2 46 54
CARVEDILOL 137 127 47 32
FLUTICASONE PROPIONATE 136 122 48 33
METFORMIN HCL 136 106 48 8
LYRICA 130 109 50 77
GLIMEPIRIDE 130 124 50 35
SEROQUEL 119 97 52 173
CIPROFLOXACIN HCL 118 111 53 66
SPIRIVA 117 94 54 48
OXYCODONE HCL 115 72 S2 55 57
DIVALPROEX SODIUM ER 115 20 55 135
AMOX TR-POTASSIUM CLAVULANATE 114 102 57 124
IPRATROPIUM-ALBUTEROL 113 89 58 126
KETOCONAZOLE 103 62 59 201
NEXIUM 103 72 59 41
DIGOXIN 102 102 61 47
CARBAMAZEPINE 101 54 62 136
NYSTATIN 99 84 63 182
ADVAIR DISKUS 99 86 63 46
LEVOFLOXACIN 98 90 65 144
RISPERIDONE 98 74 65 58
ZOLPIDEM TARTRATE 96 76 67 14
NYSTOP 96 93 67 181
OLANZAPINE 95 71 69 73
MELOXICAM 95 85 69 26
PROPRANOLOL HCL 93 57 71 92
PAROXETINE HCL 92 74 72 51
OXYCODONE HCL-ACETAMINOPHEN 91 73 S2 73 142
DILTIAZEM 24HR CD 90 86 74 98
METHADONE HCL 86 56 S2 75 65
TIZANIDINE HCL 83 15 76 129
SULFAMETHOXAZOLE-TRIMETHOPRIM 80 65 77 90
PRAVASTATIN SODIUM 78 68 78 20
FLUOXETINE HCL 77 49 79 28
CLOPIDOGREL 75 63 80 91
BUMETANIDE 74 69 81 167
JANUVIA 72 72 82 99
AMLODIPINE BESYLATE-BENAZEPRIL 72 70 82 92
RANITIDINE HCL 72 60 82 39
PHENYTOIN SODIUM EXTENDED 72 48 82 160
PANTOPRAZOLE SODIUM 71 66 86 62
DIVALPROEX SODIUM 70 41 87 86
METOCLOPRAMIDE HCL 67 36 88 111
GLIPIZIDE ER 65 62 89 95
DESONIDE 64 62 90 226
ENALAPRIL MALEATE 64 56 90 80
BENAZEPRIL HCL 64 64 90 67
OXYCODONE-ACETAMINOPHEN 63 63 S2 93 150
OXYBUTYNIN CHLORIDE 62 62 94 99
DOXAZOSIN MESYLATE 61 61 95 63
PLAVIX 60 53 96 143
LANTUS SOLOSTAR 60 56 96 72
MORPHINE SULFATE 59 58 S2 98 192
DIOVAN 59 59 98 74
KLOR-CON 10 58 46 100 137
FINASTERIDE 58 58 100 105
ISOSORBIDE MONONITRATE ER 57 56 102 79
ESTRADIOL 56 51 R 103 68
PREVACID 55 34 104 247
PREMARIN 55 52 R 104 89
DOXYCYCLINE HYCLATE 54 50 106 127
CLONIDINE HCL 54 33 106 82
GLIPIZIDE 53 40 108 84
CELEBREX 53 43 108 103
BUPROPION XL 53 40 108 97
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 50 108 24
NITROFURANTOIN MONO-MACRO 53 41 108 165
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 48 113 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 22, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.